|  Help  |  About  |  Contact Us

Publication : Virus-induced senescence is a driver and therapeutic target in COVID-19.

First Author  Lee S Year  2021
Journal  Nature Volume  599
Issue  7884 Pages  283-289
PubMed ID  34517409 Mgi Jnum  J:334872
Mgi Id  MGI:7294121 Doi  10.1038/s41586-021-03995-1
Citation  Lee S, et al. (2021) Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 599(7884):283-289
abstractText  Derailed cytokine and immune cell networks account for the organ damage and the clinical severity of COVID-19 (refs. (1-4)). Here we show that SARS-CoV-2, like other viruses, evokes cellular senescence as a primary stress response in infected cells. Virus-induced senescence (VIS) is indistinguishable from other forms of cellular senescence and is accompanied by a senescence-associated secretory phenotype (SASP), which comprises pro-inflammatory cytokines, extracellular-matrix-active factors and pro-coagulatory mediators(5-7). Patients with COVID-19 displayed markers of senescence in their airway mucosa in situ and increased serum levels of SASP factors. In vitro assays demonstrated macrophage activation with SASP-reminiscent secretion, complement lysis and SASP-amplifying secondary senescence of endothelial cells, which mirrored hallmark features of COVID-19 such as macrophage and neutrophil infiltration, endothelial damage and widespread thrombosis in affected lung tissue(1,8,9). Moreover, supernatant from VIS cells, including SARS-CoV-2-induced senescence, induced neutrophil extracellular trap formation and activation of platelets and the clotting cascade. Senolytics such as navitoclax and a combination of dasatinib plus quercetin selectively eliminated VIS cells, mitigated COVID-19-reminiscent lung disease and reduced inflammation in SARS-CoV-2-infected hamsters and mice. Our findings mark VIS as a pathogenic trigger of COVID-19-related cytokine escalation and organ damage, and suggest that senolytic targeting of virus-infected cells is a treatment option against SARS-CoV-2 and perhaps other viral infections.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression